An official website of the United States government
Home
Name
TPCH
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for TPCH
Name
Alternate Names
6-Mercaptoguanine
6-Thioguanine
Lanvis
Tabloid
Tioguanin
WR-1141
Abbreviations
6-TG
TG
TT-6
TT-G
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
752
000752
Primary Site
None
Histology
None
Remarks
A purine analogue antineoplastic agent; antimetabolite. FDA approved use for acute non-lymphocytic leukemia.
Coding
This drug should be coded
Name
Alternate Names
Belustine (nitrosourea)
CeeNu
Chloroethylcyclohexylnitrosourea
ICIG 1109
RB1509
WR-139017
Abbreviations
CCNU
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
079037
79037
Primary Site
Histology
None
Remarks
Cell-cycle nonspecific antineoplastic agent;alkylating agent. FDA approved uses in brain tumor and Hodgkin's lymphoma.
Coding
This drug should be coded
Name
Alternate Names
Ibenzmethyzin Hydrochloride
Matulane
Methylhydrazine
N-Methylhydrazine
Natulan
Natulane
Procarbazine hydrochloride
Ro-4-6467
Ro4-6467/1
Abbreviations
IBZ
MIH
PCB
PCH
PCI
PCZ
Category
Chemotherapy
Subcategory
Nonclassic alkylating agent
NSC Number
077213
77213
Primary Site
Histology
None
Remarks
An orally administered hydrazine derivative antineoplastic agent. FDA approved in stages III, IV Hodgkin's lymphoma.
Coding
This drug should be coded
Name
Alternate Names
Carbamo-hydroximic acid
Carbamohydroxamic acid
Carbamoyl oxime
Droxia
Hidrix
Hydrea
Hydreia
hydroxy-
Hydroxycarbamide
Hydroxycarbamine
Hydroxyl-urea
Hydura
Litaler
Litalir
Onco-Carbide
Oxyurea
SQ-1089
Urea
WR-83799
Abbreviations
HU
HUR
HYD
Category
Chemotherapy
Subcategory
Miscellaneous agent
NSC Number
032065
32065
Primary Site
Histology
None
Remarks
FDA approved uses on chronic myelogenous leukemia, head and neck cancers, melanoma, and advanced ovarian cancer.
Coding
This drug should be coded
